Kane to Showcase revyve® at Wounds Canada National Hybrid Conference
Engaging Canadian wound-care professionals, presenting data and discussing biofilm management in clinical practice WINNIPEG, Manitoba, Oct.
19, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane”
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.